Buy CME stocks now with Interactive Brokers – the most advanced investment platform
- Performance
- Key stats
- Financials
- US politician trades
CME stock trades by the US Senators and Representatives
In the last 12 months Finbold has discovered a total of 1 CME trades made by 1 politicians. The the same period there was a total of 1 buy trades amounting to $1K - $15K , and 0 sell trades . Based on this information, it appears that 100.00% of the total politicians preferred to buy CME Group Inc. stock, while none of the politicians preferred to sell CME Group Inc. stock.
The largest recorded CME stock trade by the US politician in the last 12 months was made by Kathy Manning , with a disclosed amount of between $1K - $15K .
CME stock does not seem to have any one politician who would have done more than one CME Group Inc. stock trade in the last 12 months.
Percentage
October 2024
Senator | Action | Amount | Date | Owner | Type |
---|---|---|---|---|---|
Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
Unlock All Transactions As They Come
Upgrade now to access all U.S. politician trades for this and other stocks. Get the latest signals as they come.
March 2024
Name | Action | Traded at | Amount | |
---|---|---|---|---|
Kathy ManningCongressman |
Purchase |
January 23
February 6
|
$1K - $15K |
Signal Details
Kathy ManningCongressman
Action
Purchase
Traded at
January 23
Disclosed at
February 6
Amount
1K - $15K
Owner
Self
|
Methodology:
For trading activity of US Members of Congress, we collect data from the Financial Disclosures website. For US Senate trading activity, the data is collected from the United States Senate Financial Disclosures (eFD) website.
The price change since the date of disclosure is calculated by comparing the stock's closing price on the date of the disclosure to the current price of the asset.